Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic inhibition affinity of copper (II) complex and their diazenyl pyridinone heterocyclic ligands against SARS-CoV2

Therapeutic inhibition affinity of copper (II) complex and their diazenyl pyridinone heterocyclic ligands against SARS-CoV2

US Patent 11786537 · Granted Oct 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridine derivatives for the treatment of hyperproliferative diseases2022
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Di(2-aryl hydrozonopropanal) arene derivatives2021
Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitum2021
Potent cytotoxic agent against human hepatocellular carcinoma cell line based on2019
Antimicrobial and cytotoxic compounds and methods for treating cancer, a bacteri2019
Method for making a phosphorus ylide2012